Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer
about
Cellular senescence in aging and age-related disease: from mechanisms to therapyCompound A Inhibits Bladder Cancer Growth Predominantly via Glucocorticoid Receptor TransrepressionGlucocorticoid receptor status is a principal determinant of variability in the sensitivity of non-small-cell lung cancer cells to pemetrexed.Potential interactions of prescription and over-the-counter medications having antioxidant capabilities with radiation and chemotherapy.Linking DNA Damage and Hormone Signaling Pathways in Cancer.Oct-1 modifies S100A4 exchange between intra- and extracellular compartments in Namalwa cells and increases their sensitivity to glucocorticoids.Glucocorticoid Receptor-Targeted Liposomal Codelivery of Lipophilic Drug and Anti-Hsp90 Gene: Strategy to Induce Drug-Sensitivity, EMT-Reversal, and Reduced Malignancy in Aggressive Tumors.Glucocorticoids may compromise the effect of gefitinib in non-small cell lung cancer.Premature aging/senescence in cancer cells facing therapy: good or bad?mTOR inhibitors blunt the p53 response to nucleolar stress by regulating RPL11 and MDM2 levels.Switch of glycolysis to gluconeogenesis by dexamethasone for treatment of hepatocarcinoma.Significance of glucocorticoid receptor expression in patients with non-small cell lung cancer treated with pemetrexed-based chemotherapy.Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression.DNA damage induced by human CD40 ligand mutant promotes senescence and induces demethylation of GATA4 in lung cancer.
P2860
Q26773500-E8B3016C-1BAD-41A6-94A1-2B4E6BF35E1CQ33631526-F501BD18-713F-43B0-9C99-1EB80489A6CEQ33821215-C334292D-99AD-4549-9B75-CA6050229B4CQ34438605-932CB21B-0E1F-46BC-83AD-DA90CDB83BEEQ36730819-59249EF9-04FF-4FDF-93A4-28958EBEE819Q37068056-8D4E8257-1F6F-41FB-837F-2D7485F38C69Q37644744-710C345C-52D2-4134-8892-2C13CB0C26B5Q37699154-89F91E21-7075-4607-9596-325984A6D69FQ38578680-59E2C28F-D41D-4AC9-B071-6BE8B43E969AQ38931429-7276F2AB-3993-42F3-A7E6-69307B941267Q43978568-B42F1FFB-6B0C-4628-B226-15081037F7B4Q48014525-01DF6360-F74E-4AC9-92AF-8887F6827BBAQ51736337-2CC2F21F-A98B-484F-A193-468FEED6F2B8Q52642947-F7C18C1B-99D7-44E1-93F5-6443BB9111CB
P2860
Dexamethasone reduces sensitivity to cisplatin by blunting p53-dependent cellular senescence in non-small cell lung cancer
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@ast
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@en
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@nl
type
label
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@ast
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@en
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@nl
prefLabel
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@ast
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@en
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@nl
P2093
P2860
P1433
P1476
Dexamethasone reduces sensitiv ...... in non-small cell lung cancer
@en
P2093
Chunxue Bai
Dongli Song
Lingyan Wang
Songshi Ni
Xingan Wang
Yuanlin Song
P2860
P304
P356
10.1371/JOURNAL.PONE.0051821
P407
P577
2012-01-01T00:00:00Z